Kwangdong Pharmaceutical광동제약
009290 · KOSPI · ₩009290 · 광동제약
₩6,310▼ ₩60 (0.94%)End-of-day · Oct 29, 2026 · End-of-day prices.
Filings
- Advance Notice of Earnings Results Disclosure (Informational Disclosure)결산실적공시예고(안내공시)Oct 30, 2026Open on DART
Predicted impact: Low
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 12, 2026Open on DART
Predicted impact: Low· Actual: −8.4% vs sector, volume 1.2× normal (5 trading days)
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 2, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Aug 28, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Aug 12, 2026Open on DART
- Advance Notice of Earnings Results Disclosure (Informational Disclosure)결산실적공시예고(안내공시)Jul 31, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 22, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 30, 2026Open on DART
- Disclosure Related to Sustainability Management Report, etc. (Voluntary Disclosure)지속가능경영보고서등관련사항(자율공시)Jun 26, 2026Open on DART
- Disclosure of Corporate Governance Report기업지배구조보고서공시May 29, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 14, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 26, 2026Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Mar 26, 2026Open on DART
- Audit report submitted감사보고서제출Mar 18, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 10, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Mar 9, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 9, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 9, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 9, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 9, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Feb 27, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Feb 25, 2026Open on DART
- Cash dividend decision현금ㆍ현물배당결정Feb 23, 2026Open on DART
- Shareholder Register Closure for Cash/Stock Dividend (Record Date) Decision현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정Feb 23, 2026Open on DART
- Other management matters기타경영사항(자율공시)Feb 23, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Feb 23, 2026Open on DART
- Change in revenue or profit of 30% or more매출액또는손익구조30%(대규모법인은15%)이상변경Feb 10, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Jan 22, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Dec 31, 2025Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Dec 24, 2025Open on DART
- Share cancellation decision주식소각결정Dec 23, 2025Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Dec 23, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 12, 2025Open on DART
- Change of Representative Director (Representative Executive Officer) (Informational Disclosure)대표이사(대표집행임원)변경(안내공시)Dec 4, 2025Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Dec 4, 2025Open on DART
- Designation as Company for Unfaithful Disclosure불성실공시법인지정Nov 20, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Notice of Planned Designation as Unfaithful Disclosure Company불성실공시법인지정예고Oct 30, 2025Open on DART
- Amended: Treasury share sale decision[기재정정]주요사항보고서(자기주식처분결정)Oct 28, 2025Open on DART
- Amended: Exchangeable bond issue decision[기재정정]주요사항보고서(교환사채권발행결정)Oct 28, 2025Open on DART
- Treasury share sale decision정정명령부과( 2025.10.20. 제출 주요사항보고서(자기주식 처분 결정) )Oct 23, 2025Open on DART
- Exchangeable bond issue decision정정명령부과( 2025.10.20. 제출 주요사항보고서(교환사채권 발행결정) )Oct 23, 2025Open on DART
- Correction ordered: Treasury share sale decision[정정명령부과]주요사항보고서(자기주식처분결정)Oct 20, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Kwangdong Pharmaceutical / 광동제약 / 009290 / KRX:009290
Source: KRX statistical information